Cargando…

The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic

The emergence and global impact of COVID-19 has focused the scientific and medical community on the pivotal influential role of respiratory viruses as causes of severe pneumonia, on the understanding of the underlying pathomechanisms, and on potential treatment for COVID-19. The latter concentrates...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aigner, Ludwig, Pietrantonio, Frank, Bessa de Sousa, Diana Marisa, Michael, Johanna, Schuster, Daniela, Reitsamer, Herbert Anton, Zerbe, Horst, Studnicka, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773944/ https://www.ncbi.nlm.nih.gov/pubmed/33392263 http://dx.doi.org/10.3389/fmolb.2020.610132

Ejemplares similares

The Leukotriene Receptor Antagonist Montelukast Attenuates Neuroinflammation and Affects Cognition in Transgenic 5xFAD Mice
por: Michael, Johanna, et al.
Publicado: (2021)

Improved Bioavailability of Montelukast through a Novel Oral Mucoadhesive Film in Humans and Mice
por: Michael, Johanna, et al.
Publicado: (2020)

Montelukast: More than a Cysteinyl Leukotriene Receptor Antagonist?
por: Tintinger, Gregory R., et al.
Publicado: (2010)

Cysteinyl leukotriene receptor 1 modulates autophagic activity in retinal pigment epithelial cells
por: Koller, Andreas, et al.
Publicado: (2020)

Exercise-induced bronchoconstriction: The effects of montelukast, a leukotriene receptor antagonist
por: Kemp, James P
Publicado: (2009)

Leukotriene Signaling as a Target in α-Synucleinopathies
por: Strempfl, Katharina, et al.
Publicado: (2022)

The Leukotriene Receptor Antagonist Montelukast Reduces Alpha-Synuclein Load and Restores Memory in an Animal Model of Dementia with Lewy Bodies
por: Marschallinger, Julia, et al.
Publicado: (2020)

Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson’s Disease
por: Wallin, Johan, et al.
Publicado: (2021)

The platelet transcriptome and proteome in Alzheimer’s disease and aging: an exploratory cross-sectional study
por: de Sousa, Diana M. Bessa, et al.
Publicado: (2023)

Beneficial effects montelukast, cysteinyl-leukotriene receptor antagonist, on renal damage after unilateral ureteral obstruction in rats
por: Otunctemur, Alper, et al.
Publicado: (2015)

Leukotrienes vs. Montelukast—Activity, Metabolism, and Toxicity Hints for Repurposing
por: Marques, Cátia F., et al.
Publicado: (2022)

170 Combination of a Nasal Antihistamine Olopatadine and A Leukotriene Receptor Antagonist Montelukast Sodium for the Treatment of Seasonal Allergic Patients not Currently Controlled on Monotherapy Intranasal Antihistamine or a Leukotriene Receptor Antagonist
por: Nsouli, Safa
Publicado: (2012)

Effects of oral cysteine leukotriene receptor antagonist-montelukast on adenoid lymphoid tissue: a histopathological study under light microscope
por: Wang, Zhengying, et al.
Publicado: (2023)

Editorial: Enzymes Regulating the Homeostasis of Agonists and Antagonists of the N-Methyl D-Aspartate Receptors
por: Mozzarelli, Andrea, et al.
Publicado: (2019)

Chronobiological activity of cysteinyl leukotriene receptor 1 during basal and induced autophagy in the ARPE-19 retinal pigment epithelial cell line
por: Koller, Andreas, et al.
Publicado: (2021)

Designer Leptin Receptor Antagonist Allo-aca Inhibits VEGF Effects in Ophthalmic Neoangiogenesis Models
por: Coroniti, Roberta, et al.
Publicado: (2016)

Antagonistic Control of Genetic Circuit Performance for Rapid Analysis of Targeted Enzyme Activity in Living Cells
por: Kwon, Kil Koang, et al.
Publicado: (2021)

Glycomimetic antagonists of BC2L-C lectin: insights from molecular dynamics simulations
por: Antonini, Giulia, et al.
Publicado: (2023)

Leukotriene Antagonists in Dermatology
por: Bubna, Aditya Kumar
Publicado: (2021)

Corrigendum: Designer Leptin Receptor Antagonist Allo-aca Inhibits VEGF Effects in Ophthalmic Neoangiogenesis Models
por: Coroniti, Roberta, et al.
Publicado: (2016)

Montelukast, a Cysteinyl Leukotriene Receptor 1 Antagonist, Induces M2 Macrophage Polarization and Inhibits Murine Aortic Aneurysm Formation
por: Kawai, Yohei, et al.
Publicado: (2019)

The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis
por: Torres, Sandra, et al.
Publicado: (2021)

Binding Mechanisms of Intrinsically Disordered Proteins: Theory, Simulation, and Experiment
por: Mollica, Luca, et al.
Publicado: (2016)

Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: The enigmatic entity
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021)

Potential antagonistic relationship of fgf9 and rspo1 genes in WNT4 pathway to regulate the sex differentiation in Chinese giant salamander (Andrias davidianus)
por: Zhang, Jiankang, et al.
Publicado: (2022)

Mathematical Modeling of Proliferative Immune Response Initiated by Interactions Between Classical Antigen-Presenting Cells Under Joint Antagonistic IL-2 and IL-4 Signaling
por: Atitey, Komlan, et al.
Publicado: (2022)

Genome Segregation by the Venus Flytrap Mechanism: Probing the Interaction Between the ParF ATPase and the ParG Centromere Binding Protein
por: Caccamo, Marisa, et al.
Publicado: (2020)

The effect of montelukast, a leukotriene receptor antagonist, on the acetic acid-induced model of colitis in rats: Involvement of NO-cGMP-K(ATP) channels pathway
por: Ghorbanzadeh, Behnam, et al.
Publicado: (2022)

Leukotriene Receptor Antagonist, Montelukast Ameliorates L-NAME-Induced Pre-eclampsia in Rats through Suppressing the IL-6/Jak2/STAT3 Signaling Pathway
por: Abdelzaher, Walaa Yehia, et al.
Publicado: (2022)

Editorial: The Dual-Use Dilemma for Biomimicry
por: Damiati, Samar, et al.
Publicado: (2022)

Host Cell Glycocalyx Remodeling Reveals SARS-CoV-2 Spike Protein Glycomic Binding Sites
por: Sheng, Ying, et al.
Publicado: (2022)

Principles and functions of condensate modifying drugs
por: Patel, Avinash, et al.
Publicado: (2022)

Structural mechanisms of chaperone mediated protein disaggregation
por: Sousa, Rui
Publicado: (2014)

Montelukast Inhibits Lung Cancer Cell Migration by Suppressing Cysteinyl Leukotriene Receptor 1 Expression In vitro
por: Chen, Yisheng, et al.
Publicado: (2023)

The role of molecular chaperones in clathrin mediated vesicular trafficking
por: Sousa, Rui, et al.
Publicado: (2015)

Editorial: Metalloproteins as sensors of gaseous small molecules—From bench to bed and beyond
por: Sousa, Eduardo H. S., et al.
Publicado: (2023)

Modeling Meets Metabolomics—The WormJam Consensus Model as Basis for Metabolic Studies in the Model Organism Caenorhabditis elegans
por: Witting, Michael, et al.
Publicado: (2018)

RNA sequencing and lipidomics uncovers novel pathomechanisms in recessive X-linked ichthyosis
por: McGeoghan, Farrell, et al.
Publicado: (2023)

Immunosuppressed Miniswine as a Model for Testing Cell Therapy Success: Experience With Implants of Human Salivary Stem/Progenitor Cell Constructs
por: Wu, Danielle, et al.
Publicado: (2021)

Editorial: Characterizing the Multi-Faceted Dynamics of Tumor Cell Plasticity
por: Tripathi, Satyendra Chandra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_60j78s3rlvtudmvggrp3kab72k